Liquid Biopsies for Assessing Metastatic Melanoma Progression. - Wikidata - wikimedia - TriplyDB

Liquid Biopsies for Assessing Metastatic Melanoma Progression.

Liquid Biopsies for Assessing Metastatic Melanoma Progression.

http://www.wikidata.org/entity/Q37667080

about

Intratumor and Intertumor Heterogeneity in Melanoma.Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine.Personalized Medicine in Malignant Melanoma: Towards Patient Tailored Treatment.

P2860

Q46742817-843E110D-7963-451C-9143-62F05D2C0012 Q47392574-496F10E2-0966-46BD-9117-C0969B9F0918 Q55352057-B92F4D49-2964-4A7F-B5BB-1BA568CCF149

P2860

Liquid Biopsies for Assessing Metastatic Melanoma Progression.

http://www.wikidata.org/entity/Q37667080

description

2016 թվականի հունվարին հրատարակված գիտական հոդված

@hy

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

name

Liquid Biopsies for Assessing Metastatic Melanoma Progression.

@en

Liquid Biopsies for Assessing Metastatic Melanoma Progression.

@nl

type

label

Liquid Biopsies for Assessing Metastatic Melanoma Progression.

@en

Liquid Biopsies for Assessing Metastatic Melanoma Progression.

@nl

prefLabel

Liquid Biopsies for Assessing Metastatic Melanoma Progression.

@en

Liquid Biopsies for Assessing Metastatic Melanoma Progression.

@nl

P1433

Q37667080-BA25420B-6185-4158-959F-874B159BF7F3

P1476

Q37667080-1D3E15FD-0BF3-40A5-B160-175B3ED340F4

P2093

Q37667080-1A552DF9-3BA9-4025-9112-200C7F7ACC06

Q37667080-A62DEC5B-100A-4B98-B525-677D8A784A93

P2860

Q37667080-01197D41-4F21-44F6-B07C-53D90014C3F1

Q37667080-02533274-8F1D-49C9-B02D-D1D421D4CED4

Q37667080-03466942-3DDE-46C1-8E9F-7350C8266721

Q37667080-0A04B8A6-B078-49F2-921E-42770658F85D

Q37667080-0D375AB1-0B42-416F-9E8C-2A65703708A8

Q37667080-13EE06C8-A525-4233-BE01-78FF403118F3

Q37667080-1AA702FD-908F-42F4-AD65-BFB86F9153C0

Q37667080-1BF02024-46AB-4AB3-A60B-6D8F938B9524

Q37667080-1D2C2981-0A20-4F23-9362-43E58BB96F98

Q37667080-21C3D65D-13DF-471C-9E93-DD5575977CFA

P304

Q37667080-CC548813-3EE9-4F05-BFEF-E8588A03F5C0

P31

Q37667080-CA2626AE-F47B-4F91-8EAA-F9187278C7C7

P356

Q37667080-5EDB6A68-1370-4616-A373-B12EA73D29C3

P407

Q37667080-AAC3D1E0-7219-4354-888A-C6ED70B601B1

P433

Q37667080-AF3F1A7D-5AF6-4669-A881-CB15E922BBB3

P478

Q37667080-2CED88E5-F1A0-400D-98E7-76AACD512BA2

P577

Q37667080-6D0D599B-AB74-4211-A1B9-F6168136BCE0

P698

Q37667080-49BC4393-4E49-4C94-BDB9-9E8745B8AC50

P921

Q37667080-7356F7F0-0FE8-4DE0-B45C-89129CD82926

P932

Q37667080-A7C9D7B9-BC08-4501-8C5C-8F024071B24D

P356

CRITREVONCOG.2016016075

P1433

Critical Reviews in Oncogenesis

P1476

Liquid Biopsies for Assessing Metastatic Melanoma Progression.

@en

P2093

Dave S B Hoon

http://www.w3.org/2001/XMLSchema#string

Kelly Huynh

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer genome landscapes

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

AIM1, a novel non-lens member of the betagamma-crystallin superfamily, is associated with the control of tumorigenicity in human malignant melanoma

Exploring the Limits of Sequence and Structure in a Variant βγ-Crystallin Domain of the Protein Absent in Melanoma-1 (AIM1)

The fundamental role of epigenetic events in cancer

Mutations of the BRAF gene in human cancer

The blockade of immune checkpoints in cancer immunotherapy

P304

141-154

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1615/CRITREVONCOG.2016016075

http://www.w3.org/2001/XMLSchema#string

P407

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27481010

http://www.w3.org/2001/XMLSchema#string

P921

P932

5326707

http://www.w3.org/2001/XMLSchema#string